The towering grey began exhibiting acute neurological signsThursdaymorning, July 25th as the result of a large mass present in multiple sinus cavities and around the optic nerves.
He was transported to Rood and Riddle Equine Hospital in Lexington, Kentuckywhere he underwent an MRI, which determined the mass was invasive and aggressive in nature and deemed inoperable.
The 20-year-old son of Unbridled stood his
entire career at Taylor Made Stallions in Nicholasville, Kentucky."Unbridled's Song was majestic from the beginning. Rarely are there horses that are supposed to be great from the beginning and actually are," said Taylor Made President & CEO Duncan Taylor. "Unbridled's Song was one of those great horses. He had it all --- looks, pedigree, speed, and presence.
"Our team loved him from the beginning. I appreciate and am proud of the job our team did with the management of this magnificent horse. I would also like to thank the breeders and owners who supported and helped him become a great stallion."
From 14 crops of progeny to race, Unbridled's Song has sired 730 winners from just over 1000 lifetime starters to date, with nearly $90 million in career progeny earnings.
Earlierthis year, his leading older horse Graydar impressively captured the Donn Handicap (G1) at Gulfstream, giving Unbridled's Song 100 career stakes winners as a sire – a landmark of triple-digit stakes winners that only 26 other stallions in North American history have accomplished.
His Australian offspring never measured up to their Northern Hemisphere counterparts, but he did leave us the top class stayer Grey Song and other stakes-winners such as Presently, Omnitrader and Zoometric.
Unbridled's Song proved to be one of the most popular commercial sires of all time in the US.
His $298,118 lifetime yearling average is best among all North American sires and ranks third all-time in North America among sires by gross yearling sales with $198,844,653 in gross sales.
